CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Lack of Association Between Heart Failure and Incident Cancer Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1 Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2

Clinical Trial2016 Jul;31(3):196-209.

JOURNAL:Cardiovasc Interv Ther. Article Link

One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

Natsuaki M, Morimoto T, Kimura T et al. Keywords: Coronary artery disease; Coronary stent; Dual antiplatelet therapy; Everolimus-eluting stent

FULL TEXT PDF